The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 23, 2017

Filed:

Nov. 17, 2014
Applicant:

Heidelberg Immunotherapeutics Gmbh, Heidelberg, DE;

Inventors:

Michael Roggendorf, Essen, DE;

Anna-Maria Eis-Hübinger, Alfter, DE;

Jürgen Krauss, Mannheim, DE;

Karl Eduard Schneweis, Bonn, DE;

Michaela Arndt, Mannheim, DE;

Adalbert Krawczyk, Mülheim, DE;

Evelyn Exner, Nuβloch, DE;

Martin P. Däumer, Kaiserslautern, DE;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07K 16/08 (2006.01);
U.S. Cl.
CPC ...
C07K 16/087 (2013.01); A61K 39/00 (2013.01); A61K 2039/505 (2013.01); C07K 2316/96 (2013.01); C07K 2317/24 (2013.01); C07K 2317/34 (2013.01); C07K 2317/54 (2013.01); C07K 2317/55 (2013.01); C07K 2317/565 (2013.01); C07K 2317/567 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01);
Abstract

The invention relates to an anti-HSV antibody as defined in the claims, a pharmaceutical composition comprising of an effective amount of the said antibody, an expression vector comprising of a nucleotide sequence which encodes the said antibody, a host cell comprising of the said nucleotide sequence, a hybridoma cell capable of producing the said antibody and the use of the said antibody as a drug, in particular to use for the manufacture of a drug for the prophylactical or therapeutical treatment of HSV-associated diseases in a subject; as defined in the claims.


Find Patent Forward Citations

Loading…